Cost-effectiveness of a Population-based Lifestyle Intervention to Promote Healthy Weight and Physical Activity in Non-attenders of Cardiac Rehabilitation

Slides:

Advertisements

Similar presentations

A Review of a Regional Primary Percutaneous Coronary Intervention Service, with a Focus on Door to Reperfusion Times: The 2012 Auckland/Northland Experience.

Advertisements

Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,

Pulmonary Vein Isolation Compared to Rate Control in Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis Kaivan Vaidya, MBBS, Clare.

Pre - Transcatheter Aortic Valve Implantation Workup in the Cardiac Catheterisation Laboratory Sarah Zaman, MBBS, PhD, Robert Gooley, MBBS, Liam McCormick,

Characterisation of Myocardial Injury via T1 Mapping in Early Reperfused Myocardial Infarction and its Relationship with Global and Regional Diastolic.

Impact of New-generation Hybrid Imaging Technology on Radiation Dose during Percutaneous Coronary Interventions and Trans-femoral Aortic Valve Implantations:

Hydrogen Sulfide Inhibits Human Platelet Aggregation In Vitro in Part by Interfering Gap Junction Channels: Effects of ACS14, a Hydrogen Sulfide-releasing.

A Randomised Controlled Trial on the Effect of Nurse-Led Educational Intervention at the Time of Catheter Ablation for Atrial Fibrillation on Quality.

Degradable Chitosan-Collagen Composites Seeded with Cells as Tissue Engineered Heart Valves Jian-Hua Fu, PhD, Man Zhao, MD, Yan-Rong Lin, BS, Xu-Dong.

Use of Aortic Homograft Conduit in Bidirectional Glenn Shunt

Jonathon P. Fanning, MBBS, Stephen V. Cox, FRACP, Gregory M

Endoscopic Radial Artery Harvesting Does not Compromise Graft Patency for Coronary Artery Bypass Graft: A Meta Analysis of 2782 Patients Hong Bing Wu,

Heart, Lung and Circulation

Systematic Detection of Familial Hypercholesterolaemia in Primary Health Care: A Community Based Prospective Study of Three Methods Andrew B. Kirke,

Procedure-specific Cardiac Surgeon Volume associated with Patient outcome following Valve Surgery, but not Isolated CABG Surgery Stephanie L. Ch’ng,

Effects of Obstructive Carotid Artery Disease on Ocular Circulation and the Safety of Carotid Artery Stenting Mehmet Yunus Emiroglu, MD, Mert Evlice,

Right Ventricular Morphology and Function in Chronic Obstructive Pulmonary Disease Patients Living at High Altitude Tolga Sinan Güvenç, MD, Hatice Betül.

Radiofrequency Ablation for Atrial Tachycardia and Atrial Flutter

Society of Thoracic Surgeons 2008 cardiac risk models predict in-hospital mortality of heart valve surgery in a Chinese population: A multicenter study

Symptom-to-Balloon Time is a Strong Predictor of Adverse Events Following Primary Percutaneous Coronary Intervention: Results From the Australian Capital.

Heart, Lung and Circulation

Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise Matteo Ziacchi, MD, PhD,

Retrospective Study of First-Generation Drug-Eluting Stents, Second-Generation Drug- Eluting Stents and Non-Drug Eluting Stent Methods in the Treatment.

Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung Sai-Hong.

Edward J. Davies, MBBS, Ben Clayton, MBChB, Ian Lines, Guy A

Cardiac Troponin and its Relationship to Cardiovascular Outcomes in Community Populations – A Systematic Review and Meta-analysis Julie Sze, MBBS, John.

Hulya Bayiz, Mert Dumantepe, Burak Teymen, Ibrahim Uyar

Stephen R. Broderick, MD, MPHS

Nuclear Cardiology Practices and Radiation Exposure in the Oceania Region: Results From the IAEA Nuclear Cardiology Protocols Study (INCAPS) Sinjini.

What Predicts Long-Term Survival After Heart Transplantation

Volume 17, Issue 2, Pages (March 2014)

Elizabeth A. David, MD, David T

Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population Christina M. Vassileva,

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Joshua E. Rosen, BASc, Hari B

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy

Mara B. Antonoff, MD, Nikki Stamp, MBBS, FRACS

Trevor Williams, MD, MPH, Brian C

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

The surgical and interventional hybrid era: Experiences from China

Health Care Use and Associated Time and Out of Pocket Expenditures for Patients With Cardiovascular Disease in a Publicly Funded Health Care System Saba.

Pulmonary Metastasectomy: A Survey of Current Practice Amongst Members of the European Society of Thoracic Surgeons Eveline Internullo, MD, Stephen D.

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

William M. DeCampli, MD, PhD

Trevor Williams, MD, MPH, Brian C

A Combined Prognostic Serum Interleukin-8 and Interleukin-6 Classifier for Stage 1 Lung Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening.

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

Tom Kai Ming Wang, MBCHB, David H. M

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Use of Amiodarone After Major Lung Resection

Volume 57, Issue 6, Pages (June 2000)

Susan C. Miller, PhD, Dan K. Kiely, MPH, MA, Joan M

Jaimin R. Trivedi, MD, MPH, Allen Cheng, MD, Michele Gallo, MD, Erin M

Stephen R. Broderick, MD, MPHS

Pulmonary Resection for Lung Cancer in Octogenarians

Volume 10, Issue 4, Pages (April 2013)

Uma M. Sachdeva, MD, PhD, Daniela Molena, MD

Organization news Archives of Physical Medicine and Rehabilitation

Ethnic Differences in the Management of Lung Cancer in New Zealand

Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD

Volume 64, Issue 5, Pages (November 2003)

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Nutrition During Trimodality Treatment in Stage III Non-small Cell Lung Cancer: Not Only Important for Underweight Patients Barbara S. van der Meij,

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

A Review of First-Line Treatment for Small-cell Lung Cancer

Hari Padmanabhan, MRCP, Matthew J. Brookes, PhD, Alan M

Presentation transcript:

Cost-effectiveness of a Population-based Lifestyle Intervention to Promote Healthy Weight and Physical Activity in Non-attenders of Cardiac Rehabilitation Qinglu Cheng, MSc, Jody Church, MA, Marion Haas, MPH, PhD, Stephen Goodall, MSc, PhD, Janice Sangster, MPH, PhD, Susan Furber, MPH, PhD Heart, Lung and Circulation Volume 25, Issue 3, Pages 265-274 (March 2016) DOI: 10.1016/j.hlc.2015.07.002 Copyright © 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions

Figure 1 Markov model for CVD patients classified by BMI. CVD I: BMI=18.5-24.99 kg/m2, CVD II: BMI=25-29.99 kg/m2, CVD III: BMI=30-34.99 kg/m2, CVDIV: BMI≥35 kg/m2. Heart, Lung and Circulation 2016 25, 265-274DOI: (10.1016/j.hlc.2015.07.002) Copyright © 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions

Figure 2 One-way sensitivity analysis for HW and control group (males). Heart, Lung and Circulation 2016 25, 265-274DOI: (10.1016/j.hlc.2015.07.002) Copyright © 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions

Figure 3 Cost-effectiveness acceptability curve. Heart, Lung and Circulation 2016 25, 265-274DOI: (10.1016/j.hlc.2015.07.002) Copyright © 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions